After ten months of a global pandemic, the search for a “safe and effective” vaccine against the new coronavirus continues. The central government expects between 400 and 500 million doses of the vaccine to be available in India by the middle of next year. Union Health Minister Dr. Harsh Vardhan …
Read More »India’s First Coronavirus Vaccine – Here’s Everything We Know About Its Development
The entire world is anxiously waiting for an effective vaccine to fight the coronavirus pandemic. Not only has it claimed lives, it has affected people, both physically and mentally. There are over 170 vaccines in progress at the moment, but closer to home we have our hopes pinned on India’s …
Read More »Coronavirus | Vaccine priority based on occupational hazards, risk of exposure, says Harsh Vardhan
Harsh Vardhan said that “the authorization of emergency use for the COVID-19 vaccine will depend on data from clinical trials.” Union Health Minister Harsh Vardhan said on Sunday that his ministry will soon launch the FELUDA paper strip test for the diagnosis of SARS-CoV-2. This has been developed by CSIR-IGIB …
Read More »Coronavirus | Active COVID-19 Cases Below 9 Lakh For Second Consecutive Day
Up to 18 states and Union Territories have recorded recovery rates above the national average, the ministry said. Active COVID-19 cases in India stayed below the nine lakh mark for the second day in a row and now constitute only 12.65 percent of the total number of cases, the Union …
Read More »Bharat Biotech signs an adjuvant pact to stimulate the immune response of Covaxin
NEW DELHI : Bharat Biotech International Ltd will use the adjuvant Alhydroxiquim-II to stimulate the immune response and provide longer-lasting immunity for its new coronavirus candidate vaccine, Covaxin, the company said in a statement Monday. The adjuvant is used under a license agreement signed with ViroVax LLC, based in the …
Read More »Bharat Biotech will test and distribute a single dose intranasal Covid-19 vaccine
Vaccine maker Bharat Biotech has acquired the rights to distribute a single-dose intranasal vaccine for Covid-19, which is currently being tested. On Wednesday, Hyderabad-based Bharat Biotech International Limited announced a licensing agreement with the Washington University School of Medicine in St. Louis for the novel chimpanzee adenovirus. Under the agreement, …
Read More »Behind the scenes of the Covid-19 vaccine trials
The desire to help, nationalism, and a sense of wanting to be part of history are some of the reasons that drive volunteers to participate in vaccine trials. Being part of a vaccine trial for a disease as little-known and virulent as Covid-19 can be both an act of courage …
Read More »Dr. Reddy’s-Sputnik V Agreement, Could India Get Covid-19 Vaccine This Year?
Written by Prabha Raghavan, edited by Explained Desk | New Delhi | Updated: September 18, 2020 12:25:23 pm A new vaccine is on display at the Nikolai Gamaleya National Center for Epidemiology and Microbiology in Moscow, Russia. (AP) Pharmacist Dr. Reddy’s Laboratories (DRL) announced on Wednesday (September 16) that it …
Read More »Government in talks with Russia for ‘possible advance’ of Sputnik V in India
The central government informed the Lok Sabha on Friday that India is in contact with Russia to advance trials of the COVID-19 vaccine – Sputnik V – in the country, according to the news agency. PTI. India is “exploring the possibility of cooperation between the two countries to promote the …
Read More »COVID-19 vaccine in India early next year? The health minister is hopeful
More than six months after a global pandemic, the search for a “safe and effective” vaccine against the new coronavirus continues. When will India get a COVID-19 vaccine? In response to this question, Union Health Minister Harsh Vardhan said on Thursday that the COVID-19 vaccine could be available in India …
Read More »